The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, 450052, China
NCT Number: NCT07229560
This is a phase I study to evaluate the effect of Itraconazole on the pharmacokinetics of HRS-8080 in healthy participants and the safety of HRS-8080 administered alone and in combination with Itraconazole in healthy participants.
Looking for future studies?
Notify Me18 year–55 year
All sexes
Interventional
Phase 1
Zhengzhou, Henan, 450052, China
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
HRS-8080 tablet, specified dose on specified days.
Itraconazole capsule, specified dose on specified days.
Time frame: From Day 1 to Day 11.
Time frame: From Day 1 to Day 11.
Time frame: From Day 1 to Day 11.
Time frame: From Day 1 to Day 11.
Time frame: From Day 1 to Day 11.
Time frame: From Day 1 to Day 11.
Time frame: From Day 1 to Day 11.
Time frame: From Day 1 to Day 17.
Time frame: From Day 1 to Day 17.
Shandong Suncadia Medicine Co., Ltd.
Industry
The Effect of Itraconazole on the Pharmacokinetics of Orally Administered HRS-8080 in Healthy Participants: A Single-Center, Single-Arm, Open-Label, Fixed-Sequence Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06995703
Breast Cancer, Breast Diseases
Lancaster, Pennsylvania, United States
View Trial DetailsNCT05316389
Breast Cancer, Breast Diseases
Angers, France
View Trial DetailsNCT07448467
Breast Cancer, Breast Diseases
Adana, Turkey (Türkiye)
View Trial DetailsNCT07760714
Breast Cancer, Breast Diseases
East Hanover, New Jersey, United States
View Trial Details